Biggest indicators for weight loss drugs are yet to come, says Jim Cramer

Are weight loss drugs to blame for a decline in gym sign-ups? Jim Cramer investigatesПодробнее

The apparel space could stand to benefit from the rise of weight-loss drugs, says Jim CramerПодробнее

Jim Cramer takes a closer look at stocks that could be impacted by weight-loss drugsПодробнее

Are weight loss drugs really the holy grail?Подробнее

Why Jim Cramer says Best Buy's earnings report is an important indicatorПодробнее

Jim Cramer takes a closer look at stock market effects from diabetic and weight-loss drugsПодробнее

We should start looking at stocks that benefit from weight-loss drugs, says Jim CramerПодробнее

Eli Lilly's weight-loss drug could be the best selling drug of all time, says Jim CramerПодробнее

Jim Cramer explains why he favors Eli Lilly in the weight loss drug spaceПодробнее

Jim Cramer talks today's best and worst performersПодробнее

Jim Cramer looks at the latest notes moving big namesПодробнее

Moments of panic are when you need to just be patient and opportunistic, says Jim CramerПодробнее

Jim Cramer Now Sees Value In Drug Stock Valeant After Its CEO ‘Delivered’Подробнее

I find it hard to believe this is as good as it gets for PepsiCo, says Jim CramerПодробнее

Jim Cramer Says It's 'Very Hard To Put A Price On' Lifesaving Drugs | CNBCПодробнее

Use this period of weakness to buy the 'best beaten down stocks', says Jim CramerПодробнее

Jim Cramer looks at turbulence in the airline stocksПодробнее

Jim Cramer: Investors should eye these 5 downtrodden stocksПодробнее